• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对血压管理的巴西移动应用程序的内容分析:系统检索

Content Analysis of Brazilian Mobile Applications Targeting Blood Pressure Management: A Systematic Search.

作者信息

Johann Eduardo Braghini, Baggio Marcelo, Pauli Nicolle Abreu, Dilli Artur, Ilkiu Rafael Teixeira, Ritti-Dias Raphael Mendes, Gerage Aline Mendes

机构信息

Grupo de pesquisa em exercício clínico (GPEC) - Universidade Federal de Santa Catarina, Florianópolis, SC - Brasil.

Programa de Pós-Graduação em Educação Física, Centro de Desportos - Universidade Federal de Santa Catarina, Florianópolis, SC - Brasil.

出版信息

Arq Bras Cardiol. 2025 Feb 10;122(2):e20240339. doi: 10.36660/abc.20240339. eCollection 2025.

DOI:10.36660/abc.20240339
PMID:39936738
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11805575/
Abstract

BACKGROUND

Several mobile applications have been developed to assist in managing hypertension, but little is known about their quality in the Brazilian scenario.

OBJECTIVE

To identify and analyze the quality of the apps targeting blood pressure (BP) management available in Portuguese.

METHODS

A systematic search was carried out through Brazilian virtual app stores in the Android and iOS platforms from November 2021 to March 2022, with an update in March 2024. The search was based on the standards of systematic review (PRISMA), using predefined keywords, including apps in Portuguese, free and available for use during the search. Three independent reviewers analyzed the apps using the five-point Mobile App Rating Scale (MARS), and for the presence of tools/content related to the BP control.

RESULTS

Fifty-six applications met the criteria for data extraction. The most prevalent tool was the recording of BP values (98%). The tool for adherence to medication and reminders to their use was present in only 29% and 34% of the APPs, respectively. The mean overall MARS score was 3.4 ± 0.74 and 3.1 ± 0.61 for Android and iOS APPs, respectively, which classified then as acceptable. The best rated item was "functionality" for both Android and iOS apps.

CONCLUSION

The present study identified numerous apps with acceptable quality aimed at monitoring BP. However, most of them did not include important factors related to disease control, particularly regarding treatment adherence, physical activity and presence of comorbidities.

摘要

背景

已经开发了几种移动应用程序来辅助管理高血压,但在巴西的情况下,对其质量了解甚少。

目的

识别并分析以葡萄牙语提供的用于血压管理的应用程序的质量。

方法

于2021年11月至2022年3月通过巴西安卓和iOS平台的虚拟应用商店进行了系统搜索,并于2024年3月进行了更新。该搜索基于系统评价标准(PRISMA),使用预定义的关键词,包括葡萄牙语应用程序、免费且在搜索期间可供使用的应用程序。三名独立评审员使用五点移动应用评分量表(MARS)对应用程序进行分析,并查看是否存在与血压控制相关的工具/内容。

结果

56个应用程序符合数据提取标准。最普遍的工具是血压值记录(98%)。仅分别有29%和34%的应用程序具备服药依从性工具和用药提醒工具。安卓和iOS应用程序的平均总体MARS评分分别为3.4±0.74和3.1±0.61,均被归类为可接受。安卓和iOS应用程序中评分最高的项目都是“功能”。

结论

本研究识别出众多质量可接受的用于监测血压的应用程序。然而,其中大多数未纳入与疾病控制相关的重要因素,尤其是在治疗依从性、体育活动和合并症方面。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b507/11805575/0dc26b436727/0066-782X-abc-122-2-e20240339-gf02-en.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b507/11805575/01cc64fe62f9/0066-782X-abc-122-2-e20240339-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b507/11805575/eac4ad499b4e/0066-782X-abc-122-2-e20240339-gf02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b507/11805575/003ddb6c2066/0066-782X-abc-122-2-e20240339-gf01-en.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b507/11805575/0dc26b436727/0066-782X-abc-122-2-e20240339-gf02-en.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b507/11805575/01cc64fe62f9/0066-782X-abc-122-2-e20240339-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b507/11805575/eac4ad499b4e/0066-782X-abc-122-2-e20240339-gf02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b507/11805575/003ddb6c2066/0066-782X-abc-122-2-e20240339-gf01-en.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b507/11805575/0dc26b436727/0066-782X-abc-122-2-e20240339-gf02-en.jpg

相似文献

1
Content Analysis of Brazilian Mobile Applications Targeting Blood Pressure Management: A Systematic Search.针对血压管理的巴西移动应用程序的内容分析:系统检索
Arq Bras Cardiol. 2025 Feb 10;122(2):e20240339. doi: 10.36660/abc.20240339. eCollection 2025.
2
Mobile Apps for Blood Pressure Monitoring: Systematic Search in App Stores and Content Analysis.用于血压监测的移动应用程序:在应用商店中的系统搜索与内容分析
JMIR Mhealth Uhealth. 2018 Nov 14;6(11):e187. doi: 10.2196/mhealth.9888.
3
Smartphone Apps for Pulmonary Hypertension: Systematic Search and Content Evaluation.智能手机应用程序治疗肺动脉高压:系统搜索和内容评估。
JMIR Mhealth Uhealth. 2024 Oct 30;12:e57289. doi: 10.2196/57289.
4
Measuring the Quality of Clinical Skills Mobile Apps for Student Learning: Systematic Search, Analysis, and Comparison of Two Measurement Scales.测量临床技能移动应用程序对学生学习质量的评估:两种测量量表的系统搜索、分析和比较。
JMIR Mhealth Uhealth. 2021 Apr 23;9(4):e25377. doi: 10.2196/25377.
5
Mobile health applications for epilepsy in Indian app stores: A systematic review and content analysis using the mobile app rating scale.印度应用商店中用于癫痫的移动健康应用程序:使用移动应用评分量表的系统评价和内容分析
Epilepsy Res. 2024 Mar;201:107331. doi: 10.1016/j.eplepsyres.2024.107331. Epub 2024 Feb 22.
6
Mobile Apps for Hematological Conditions: Review and Content Analysis Using the Mobile App Rating Scale.移动应用程序在血液学疾病中的应用:使用移动应用程序评级量表进行的评价和内容分析。
JMIR Mhealth Uhealth. 2022 Feb 16;10(2):e32826. doi: 10.2196/32826.
7
Mobile Apps for Common Noncommunicable Disease Management: Systematic Search in App Stores and Evaluation Using the Mobile App Rating Scale.移动应用程序用于常见非传染性疾病管理:在应用商店中的系统搜索和使用移动应用程序评级量表进行评估。
JMIR Mhealth Uhealth. 2024 Mar 12;12:e49055. doi: 10.2196/49055.
8
Quality and Accessibility of Home Assessment mHealth Apps for Community Living: Systematic Review.家庭评估移动医疗应用程序在社区生活中的质量和可及性:系统评价。
JMIR Mhealth Uhealth. 2024 Mar 11;12:e52996. doi: 10.2196/52996.
9
Mobile Phone Apps for Food Allergies or Intolerances in App Stores: Systematic Search and Quality Assessment Using the Mobile App Rating Scale (MARS).应用商店中针对食物过敏或不耐受的手机应用程序:使用移动应用评级量表(MARS)进行系统搜索和质量评估。
JMIR Mhealth Uhealth. 2020 Sep 16;8(9):e18339. doi: 10.2196/18339.
10
Mobile Applications for Hemodialysis: Evaluation Using the Mobile App Rating Scale (MARS).用于血液透析的移动应用程序:使用移动应用程序评分量表(MARS)进行评估。
Semin Dial. 2025 Mar-Apr;38(2):102-110. doi: 10.1111/sdi.13243. Epub 2025 Feb 6.

引用本文的文献

1
Technologies for Better Blood Pressure Control: Do the Applications Offer the Necessary Quality?改善血压控制的技术:这些应用程序具备所需的质量吗?
Arq Bras Cardiol. 2025 Apr 28;122(2):e20250085. doi: 10.36660/abc.20250085. eCollection 2025.

本文引用的文献

1
Global blood pressure screening during the COVID-19 pandemic: results from the May Measurement Month 2021 campaign.全球新冠肺炎大流行期间的血压筛查:2021 年 5 月测量月活动结果。
J Hypertens. 2023 Sep 1;41(9):1446-1455. doi: 10.1097/HJH.0000000000003488. Epub 2023 Jun 19.
2
[2021 World Health Organization guideline on pharmacological treatment of hypertension: Policy implications for the Region of the AmericasDirectrices de la Organización Mundial de la Salud del 2021 sobre el tratamiento farmacológico de la hipertensión: implicaciones de política para la Región de las Américas].[《2021年世界卫生组织高血压药物治疗指南:对美洲区域的政策影响》《世界卫生组织2021年高血压药物治疗指南:对美洲区域的政策影响》]
Rev Panam Salud Publica. 2022 May 10;46:e55. doi: 10.26633/RPSP.2022.55. eCollection 2022.
3
Apps on Google Play Store to assist in self-management of hypertension in Indian context: features analysis study.谷歌应用商店中有助于印度高血压自我管理的应用程序:功能分析研究
Mhealth. 2022 Apr 20;8:14. doi: 10.21037/mhealth-21-25. eCollection 2022.
4
Identification of the Most Suitable App to Support the Self-Management of Hypertension: Systematic Selection Approach and Qualitative Study.确定最适合支持高血压自我管理的应用程序:系统选择方法和定性研究。
JMIR Mhealth Uhealth. 2021 Nov 17;9(11):e29207. doi: 10.2196/29207.
5
Brazilian Guidelines of Hypertension - 2020.《巴西高血压指南 - 2020》
Arq Bras Cardiol. 2021 Mar;116(3):516-658. doi: 10.36660/abc.20201238.
6
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.《PRISMA 2020声明:报告系统评价的更新指南》
Syst Rev. 2021 Mar 29;10(1):89. doi: 10.1186/s13643-021-01626-4.
7
Feasibility of a Digital Health Intervention to Improve Diet Quality Among Women With High Blood Pressure: Randomized Controlled Feasibility Trial.数字健康干预改善高血压女性饮食质量的可行性:随机对照可行性试验。
JMIR Mhealth Uhealth. 2020 Dec 7;8(12):e17536. doi: 10.2196/17536.
8
Impact and efficacy of mobile health intervention in the management of diabetes and hypertension: a systematic review and meta-analysis.移动健康干预在糖尿病和高血压管理中的影响及效果:一项系统综述和荟萃分析
BMJ Open Diabetes Res Care. 2020 Sep;8(1). doi: 10.1136/bmjdrc-2020-001225.
9
[Costs attributable to obesity, hypertension, and diabetes in the Unified Health System, Brazil, 2018Costos atribuibles a la obesidad, la hipertensión y la diabetes en el Sistema Único de Salud de Brasil, 2018].2018年巴西统一卫生系统中肥胖、高血压和糖尿病的归因成本
Rev Panam Salud Publica. 2020 Apr 10;44:e32. doi: 10.26633/RPSP.2020.32. eCollection 2020.
10
The Effectiveness of Self-Management of Hypertension in Adults Using Mobile Health: Systematic Review and Meta-Analysis.使用移动健康技术管理成年人高血压的效果:系统评价和荟萃分析。
JMIR Mhealth Uhealth. 2020 Mar 27;8(3):e17776. doi: 10.2196/17776.